Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-18T22:49:36.563Z Has data issue: false hasContentIssue false

371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction

Published online by Cambridge University Press:  19 April 2022

Sai Suma Samudrala
Affiliation:
Medical College of Wisconsin
Melissa Anfinson
Affiliation:
Medical College of Wisconsin
Matthew Cavanaugh
Affiliation:
Marquette University
Min-Su Kim
Affiliation:
Medical College of Wisconsin
Peter Lamberton
Affiliation:
Marquette University
Jackson Radandt
Affiliation:
Marquette University
Ryan Brown
Affiliation:
Medical College of Wisconsin
Huan Ling Liang
Affiliation:
Medical College of Wisconsin
Karl Stamm
Affiliation:
Medical College of Wisconsin
Afzal Zeeshan
Affiliation:
Medical College of Wisconsin
Jennifer Strande
Affiliation:
Medical College of Wisconsin
Michele Frommelt
Affiliation:
Childrens Wisconsin
John W. Lough
Affiliation:
Medical College of Wisconsin
Robert Fitts
Affiliation:
Marquette University
Michael E. Mitchell
Affiliation:
Medical College of Wisconsin Childrens Wisconsin
Aoy Tomita-Mitchel
Affiliation:
Medical College of Wisconsin
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/GOALS: In a familial case where 10 of 17 members inherited EA/LVNC in an autosomal dominant pattern, we discovered a novel, damaging missense variant in the gene KLHL26 that segregates with disease and comprises an altered electrostatic surface profile, likely decoupling the CUL3-interactome. We hypothesize that this KLHL26 variant is etiologic of EA/LVNC. METHODS/STUDY POPULATION: We differentiated a family trio (a heart-healthy daughter and EA/LVNC-affected mother and daughter) of induced pluripotent stem cells into cardiomyocytes (iPSC-CMs) in a blinded manner on three iPSC clones per subject. Using flow cytometry, immunofluorescence, and biomechanical, electrophysiological, and automated contraction methods, we investigated iPSC-CM differentiation efficiency between D10-20, contractility analysis and cell cycle regulation at D20, and sarcomere organization at D60. We further conducted differential analyses following label-free protein and RNA-Seq quantification at D20. Via CRISPR-Cas9 gene editing, we plan to characterize KLHL26 variant-specific iPSC-CM alterations and connect findings to discoveries from patient-specific studies. RESULTS/ANTICIPATED RESULTS: All iPSC lines differentiated into CMs with an increased percentage of cTnT+ cells in the affected daughter line. In comparison to the unaffected, affected iPSC-CMs had fewer contractions per minute and altered calcium transients, mainly a higher amount of total calcium release, faster rate of rise and faster rate of fall. The affected daughter line further had shorter shortening and relaxation times, higher proliferation, lower apoptosis, and a smaller cell surface area per cardiac nucleus. The affected mother line trended in a similar direction to the affected daughter line. There were no gross differences in sarcomere organization between the lines. We also discovered differential expression of candidate proteins such as kinase VRK1 and collagen COL5A1 from proteomic profiling. DISCUSSION/SIGNIFICANCE: These discoveries suggest that EA/LVNC characteristics or pathogenesis may result from decreased contractile ability, altered calcium transients, and cell cycle dysregulation. Through the KLHL26 variant correction and introduction in the daughter lines, we will build upon this understanding to inform exploration of critical clinical targets.

Type
Valued Approaches
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2022. The Association for Clinical and Translational Science